Abstract
Integral treatment of a patient with neuropsychiatric symptoms by the chronic consume of alcoholChronified neuropsychiatric symptoms even when they have diverse etiology, generate an important impairment for thepatient, greater family preoccupation, and high attention cost. Objectives. Describe the clinical evolution and integralmanagement of a patient with vitamins deficit for alcohol abuse. Clinical Signs. Subject is a male patient of 55 years of age,resides in San Carlos, Chile, without psychiatric backgrounds except for alcohol dependency that he suspended after beginningpsychiatric symptoms four years ago, characterized by delirious thoughts of the paranoid, mystical and nihilistic nature, alsovisual, olfactory and tactile complex hallucinations and gradual compromise of mood. Afterwards he presented paralysis ofthe superior extremities predominately proximal, and later of the inferiors, also, cognitive alterations. Other medicalpathologies where discarded and only a megaloblastic anaemia was documented, beginning treatment of vitamin supplements(B12 and folate) and an integral treatment plan with psychiatry and occupational therapist, for symptomatic treatment and,rehabilitation. Conclusions. Throughout the follow up of the interdisciplinary interventions it could be observed in the patienta progressive betterment of the neurological alterations, and in his global functions.
Key words: Megaloblastic anaemia. Neuropsychiatry. Impairment. Rehabilitation.
References
2. Reynolds EH. Benefits and risks of folic acid to the nervous system. J Neurol Neurosurg Psychiatry. 2002;72:567-71.
3. Bottiglieri T. Folate, vitamin B12 and neuropsychiatric disorders. Nutr Rev. 1996;54(12):382-90.
4. Bottiglieri T, Crellin R, Reynolds EH. Folate and neuropsychiatry. En: Reynolds EH. Benefits and risks of folic acid to the nervous system. J Neurol Neurosurg Psychiatry. 2002;72:567-71.
5. Epstein FH, Toh B, Van Driel IR, Gleeson PA. Mechanism of disease: pernicious anemia. N Engl J Med. 1997;337(20):1941-8.
6. Reynolds E. Vitamin B12, folic acid and the nervous system. Lancet. 2006;5(11):949-60.
7. Goebels N, Soyka M. Dementia associated with vitamin B12 deficiency: presentation of two cases and review of the literature. J Neuropsychiatry Clin Neurosci. 2000;12(3):389-95.
8. Roos D, Willanger R. Various degrees of dementia in selected group of gastrectomized patients with low serum B12. Acta Neurol Scand. 1977;55:363-76.
9. Nagga AK, Marcusson J. Associated physical disease in a demented population. Aging (Milano) 1998;10:440-4.
10. Cole MG, Prehal JF. Low serum vitamin B12 in Alzheimer-type dementia. Age Aging. 1984;13:101-5.
11. Martin DC, Francis J, Protech J, Huff FJ. Time dependency of cognitive recovery with cobalamin replacement: report a pilot study. J Am Geriatr Soc. 1992;40(2):168-72.
12. Stojsavljevic N, Levic Z, Drulovic J, Dragutinovic G. A 44-month clinical brain MRI follow-up in a patient with B12 deficiency. Neurology. 1997;49(3):878-81.
13. Lerner V, Kanesky M. Acute dementia with delirium due to vitamin B12 deficiency: a case report. Int J Psychiatry Med. 2002;32(2):215-20.
14. Hector M, Burton JR. What are the psychiatry manifestations of vitaminB12 deficiency?. J Am Geriatr Soc. 1988;36(12):1105-12.
15. Kwok T, Lee J, Lam L, Woo J. Vitamin B12 supplementation did not improve cognition but reduced delirium in demented patients with vitamin B12 deficiency. Arch Gerontol Geriatr. 2008;46(3):273-82.